Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
06/2005
06/15/2005EP1539739A1 Piperidinyl compounds that selectively bind integrins
06/15/2005EP1539735A1 Piperazine urea derivatives as melanocortin-4 receptor agonists
06/15/2005EP1539733A2 Azabicyclic compounds are central nervous system active agents
06/15/2005EP1539714A2 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as hiv integrase inhibitors
06/15/2005EP1539709A1 Azaisoquinoline derivatives as matrix metalloproteinase inhibitors
06/15/2005EP1539708A1 Benzimidazolones and their use as cytokine inhibitors
06/15/2005EP1539694A1 2,3-dihydro-isoindol-1-ones with mao-b inhibiting activity
06/15/2005EP1539180A2 Compounds, compositions, and methods
06/15/2005EP1539151A1 Biaryl compounds having anti-infective activity
06/15/2005EP1539150A1 Naphthalimide synthesis including amonafide synthesis and pharmaceutical preparations thereof
06/15/2005EP1539133A1 Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity
06/15/2005EP1539115A1 Methods and dosage forms for controlled delivery of paliperidone
06/15/2005EP1538907A2 Inhibitors of ftsz and uses thereof
06/15/2005EP1448560B1 3-SUBSTITUTED OXINDOLE beta 3 AGONISTS
06/15/2005EP1373240B1 Retinoid x receptor modulators
06/15/2005EP1326866B1 Substituted 3.4-dihydro-pyrido[1,2-a]pyrimidines
06/15/2005EP1325007B1 Hexahydropyrazino[1'2':1,6]-pyrido[3,4-b]indole-1,4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction
06/15/2005EP1256576B1 Fused imidazolium derivatives
06/15/2005EP1163241B1 Zolpidem salts
06/15/2005EP1020451B1 Anilide compounds and drugs containing the same
06/15/2005EP1010699B1 5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1h)-one derivatives
06/15/2005EP0975602B1 Imidazole and imidazoline derivatives and uses thereof
06/15/2005CN1628147A Fluorescent pigment composition
06/15/2005CN1628114A Coumarines useful as biomarkers
06/15/2005CN1628109A Novel aryl- and heteroarylpiperazines
06/15/2005CN1628100A Gamma secretase inhibitors
06/15/2005CN1627944A Substituted quinazolin-4-ylamine analogues as modulators of capsaicin
06/15/2005CN1626534A Steroid receptor modulator compounds and methods
06/15/2005CN1626531A Imidazole ring-containing compound and organic electroluminescence display device
06/15/2005CN1626527A Pyran derivative, method for manufacturing the same, and light-emitting element containing the pyran derivative
06/15/2005CN1206230C 4-Pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy
06/15/2005CN1206219C N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/14/2005US6906189 Catalysts and methods for catalytic oxidation
06/14/2005US6906096 Drug libraries
06/14/2005US6906075 Contacting a sample with substituted benzoimidazole analogues under conditions that permit binding of such analogue to melanin concentrating hormone (MCH) receptor to determine the presence and absence of MCH
06/14/2005US6906072 Central nervous system disorders
06/14/2005US6906066 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/14/2005US6906060 Substituted hexahydropyrrolo[1,2-a]pyrazines, octahydropyrido[1,2-a]-pyrazines and decahydropyrazino[1,2-a]azepines
06/14/2005US6906053 Antiarthritic agents; antiulcer agents; osteoporosis; antiinflammatory agents; antitumor and anticancer agents
06/14/2005US6905455 Radioactive member and method of making
06/14/2005CA2234096C 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives
06/14/2005CA2163122C Positive inotropic and lusitropic pyrroloquinolinone derivatives
06/09/2005WO2005051949A1 Novel condensed imidazole derivative
06/09/2005WO2005051906A2 Heterocyclic inhibitors of mek and methods of use thereof
06/09/2005WO2005051391A1 Quinazolinone compounds with reduced bioaccumulation
06/09/2005WO2005051386A1 Hmg-coa reductase inhibitors and method
06/09/2005WO2005051382A1 Agent enhancing lipid-loewring effect
06/09/2005WO2005051317A2 Substituted imidazo ring systems and methods
06/09/2005WO2005051302A2 Bicyclic inhibitors of mek and methods of use thereof
06/09/2005WO2005051301A2 Heterocyclic inhibitors of mek and methods of use thereof
06/09/2005WO2005051300A2 Bicyclic inhibitors of mek and methods of use thereof
06/09/2005WO2005051293A2 Methods and reagents for the treatment of inflammatory disorders
06/09/2005WO2005037198A3 Preparation of 1,7-disubstituted azabenzimidazoles as kinase inhibitors
06/09/2005WO2005028475A3 Compositions useful as inhibitors of protein kinases
06/09/2005WO2004043956A8 Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same
06/09/2005WO2003088897A3 Fab i inhibitors
06/09/2005US20050124812 Process for the synthesis of pergolide
06/09/2005US20050124682 Such as N-{2-[5-(methylthio)-1H-indol-3-yl]ethyl}acetamide for treatment of disorders of the melatoninergic system; hormone replacement therapy
06/09/2005US20050124664 Compounds for treatment of cardiovascular disorders using inhibitors of plasmnogen activator as anticoagulants for blood
06/09/2005US20050124654 Compounds and methods of use
06/09/2005US20050124650 Cyclization while heating in solvent in presence of strong acid; methylation in presence of a base; purity
06/09/2005US20050124649 Deazapurines and uses thereof
06/09/2005US20050124648 Triazolo-quinolin derivatives useful as adenosine receptor ligands
06/09/2005US20050124647 For example, 4-hydroxy-1,1-di-(5',6'-methylendioxy-indol-2-yl)-butane; antitumor agents, particularly for treating mammary carcinoma and colon carcinoma
06/09/2005US20050124640 Pyrimidine derivatives useful as inhibitors of PKC-theta
06/09/2005US20050124626 Novel compounds
06/09/2005US20050124622 Compounds and methods for the treatment of pain
06/09/2005US20050124619 Medical devices employing triazine compounds and compositions thereof
06/09/2005US20050124607 5-Substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists
06/09/2005US20050124604 E.g. 1-Benzyl-4-[4-(thiophene-2-carbonyl) piperazin-1-yl]-2-oxo-1,2-dihydro-3-cyano[1,8]-naphthyridine; antinflammatory, -arthritic, -carcinogenic, -tumor, -diabetic agents; septic shock; acute respiratory distress syndrome; casrdiovascular disorders; angiogenesis inhibitors; autoimmune diseases; asthma
06/09/2005US20050124603 Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands
06/09/2005US20050124602 1-(3-chlorophenyl)-7-oxo-6-[4-(2-oxo-1(2H)pyridinyl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide; treating a thromboembolic disorder such as deep vein thrombosis or pulmonary embolism
06/09/2005US20050124562 Using Dna polymerase inhibitor as bactericide
06/09/2005US20050123800 Organic compound and organic light emitting device using the same
06/09/2005DE10352979A1 Pyridopyrimidinone Pyridopyrimidinone
06/09/2005CA2547085A1 Hydroxylamine and oxime substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
06/09/2005CA2547020A1 1h-imidazo[4,5-c]pyridine-4-amine derivatives as immune response modifier
06/09/2005CA2546486A1 Heterocyclic inhibitors of mek and methods of use thereof
06/09/2005CA2546353A1 Bicyclic inhibitors of mek and methods of use thereof
06/09/2005CA2546347A1 Methods and reagents for the treatment of inflammatory disorders
06/09/2005CA2545660A1 Heterocyclic inhibitors of mek and methods of use thereof
06/09/2005CA2545659A1 Bicyclic inhibitors of mek
06/09/2005CA2545601A1 Quinazolinone compounds with reduced bioaccumulation
06/08/2005EP1537110A2 Triazospiro compounds having nociceptin receptor affinity
06/08/2005EP1537109A1 Novel benzonaphthyridines
06/08/2005EP1537108A1 Di and trifluoro-triazolo-pyridines anti-inflammatory compounds
06/08/2005EP1537107A2 Novel processes and intermediates for preparing triazolo-pyridines
06/08/2005EP1537106A1 Dihydropyrazolopyridine compounds
06/08/2005EP1537105A2 Synthesis of indolizines
06/08/2005EP1537102A1 Inhibition of phsphoinostide 3-dinase beta
06/08/2005EP1537089A2 Compounds compositions and methods
06/08/2005EP1537084A1 Substituted 2-alkylamine nicotinic amide derivatives and use there of
06/08/2005EP1537077A2 4-(3,3-dihalo-allyloxy) phenol derivatives having pesticidal properties
06/08/2005EP1465854A4 Chalcone derivatives and their use to treat diseases
06/08/2005EP1373269B1 Jun kinase inhibitors
06/08/2005EP1259514B1 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors
06/08/2005EP1252133B1 Pharmaceutical compounds
06/08/2005EP1068182B1 Process for preparing a protected 4-aminomethyl-pyrrolidin-3-one
06/08/2005EP1017391B1 Sustained release tablet formulation to treat parkinson disease
06/08/2005CN1625558A Aza-arylpiperazines
1 ... 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 ... 646